As there is no striking difference between the prognosis of patients with follicular carcinoma and papillary carcinoma, regulation of some other type than caveolin-1 must operate for signal transduction in follicular carcinomas. The gene discussed is CAV1; the disease is thyroid gland papillary carcinoma.